World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8639)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

426

WORD

273

HTML

3778

Figures (1-1)

118

Tables (1-2)

110

Sum=4705

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

487

Download

1090

Sum=1577

Publishing Process of This Article

Item

Count

Browse

1085

Download

1272

Sum=2357

Nov 28, 2015 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Hirten R, Sultan K, Thomas A, Bernstein DE. Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World J Hepatol 2015; 7(27): 2716-2728 [PMID: 26644815 DOI: 10.4254/wjh.v7.i27.2716]
URL:	https://www.wjgnet.com/1007-9327/full/v7/i27/2716.htm

Number	Citing Articles
1	Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
2	Patrick R. Wood, Liron Caplan. Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs. Rheumatic Disease Clinics of North America 2018; 44(1): 29 doi: 10.1016/j.rdc.2017.09.003
3	Nazli Begum Ozturk, Maria Isabel Fiel, Thomas D. Schiano. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis. JGH Open 2022; 6(9): 607 doi: 10.1002/jgh3.12795
4	Kwang Il Seo, Sang-Bum Kang. Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2019; 73(5): 248 doi: 10.4166/kjg.2019.73.5.248
5	Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828 Abstract(438) \| Core Tip(408) \| Full Article(HTML)(5042) \| Full Article (PDF)-1302K(1031) \| Full Article (Word)-246K(199) \| Audio-812K(37) \| Peer-Review Report-225K(95) \| Answering Reviewers-102K(85) \| Times Cited (7) \| Total Visits (9174) \| Open
6	Yoshiki Seto, Kouki Kato, Ryota Tsukada, Hiroki Suzuki, Yuuki Kaneko, Yoshiki Kojo, Hideyuki Sato, Satomi Onoue. Protective effects of tranilast on experimental colitis in rats. Biomedicine & Pharmacotherapy 2017; 90: 842 doi: 10.1016/j.biopha.2017.04.035
7	Akshay Patel, Andras Perl. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxidants & Redox Signaling 2022; 36(7-9): 367 doi: 10.1089/ars.2021.0068